{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:21:54Z","timestamp":1787718114082,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020908","name":"Pfizer France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020908","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ero.2025.12.001","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T10:57:35Z","timestamp":1768215455000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spondyloarthritis and inflammatory bowel disease: towards a more severe and refractory disease phenotype"],"prefix":"10.1016","volume":"2","author":[{"given":"Juliane","family":"Michel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Prati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucine","family":"Vuitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charline","family":"Vauchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Toussirot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Mauny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Puyraveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micka\u00ebl","family":"Chouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Fakih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wendling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2708-2918","authenticated-orcid":false,"given":"Frank","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ero.2025.12.001_bib0001","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/ard.2004.029207","article-title":"Prevalence of spondyloarthropathies in France: 2001","volume":"64","author":"Saraux","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ero.2025.12.001_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105289","article-title":"Differences in distribution by department of prevalence and incidence of spondyloarthritis and inflammatory bowel diseases declared to the French National Health Insurance and their evolution between 2008 and 2018","volume":"89","author":"Fakih","year":"2022","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.ero.2025.12.001_bib0003","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jbspin.2016.02.017","article-title":"The gut in spondyloarthritis","volume":"83","author":"Wendling","year":"2016","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.ero.2025.12.001_bib0004","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.semarthrit.2021.04.015","article-title":"Intestinal permeability in spondyloarthritis and rheumatoid arthritis: a systematic review of the literature","volume":"51","author":"Hecquet","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.ero.2025.12.001_bib0005","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1002\/art.27699","article-title":"Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response","volume":"62","author":"Ciccia","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"2 Pt 1","key":"10.1016\/j.ero.2025.12.001_bib0006","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0016-5085(89)91557-6","article-title":"Ileocolonoscopy in seronegative spondylarthropathy","volume":"96","author":"De Vos","year":"1989","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ero.2025.12.001_bib0007","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3899\/jrheum.181326","article-title":"Effect of gut involvement in patients with high probability of early spondyloarthritis: data from the DESIR Cohort","volume":"47","author":"Wendling","year":"2020","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.ero.2025.12.001_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001777","article-title":"Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs","volume":"8","author":"Schwartzman","year":"2022","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.ero.2025.12.001_bib0009","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of assessment of spondyloarthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ero.2025.12.001_bib0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ero.2025.12.001_bib0011","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ero.2025.12.001_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001450","article-title":"Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study","volume":"7","author":"L\u00f3pez-Medina","year":"2021","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.ero.2025.12.001_bib0013","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/rheumatology\/keaa164","article-title":"Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritis","volume":"60","author":"Luchetti","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ero.2025.12.001_bib0014","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ard.2025.01.035","article-title":"The Assessment of SpondyloArthritis International Society (ASAS) consensus-based expert definition of difficult-to-manage, including treatment-refractory, axial spondyloarthritis","volume":"84","author":"Poddubnyy","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ero.2025.12.001_bib0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.rdc.2012.09.003","article-title":"Epidemiology of spondyloarthritis","volume":"38","author":"Stolwijk","year":"2012","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.ero.2025.12.001_bib0016","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","article-title":"Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ero.2025.12.001_bib0017","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/rheumatology\/keu388","article-title":"Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS","volume":"54","author":"Essers","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ero.2025.12.001_bib0018","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/art.42289","article-title":"Both disease activity and HLA-B27 status are associated with gut microbiome dysbiosis in spondyloarthritis patients","volume":"75","author":"Berland","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.ero.2025.12.001_bib0019","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00296-005-0044-9","article-title":"The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease","volume":"26","author":"Turkcapar","year":"2006","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.ero.2025.12.001_bib0020","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ero.2025.12.001_bib0021","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaad.2016.08.022","article-title":"Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: a population-based cross-sectional study","volume":"76","author":"Kim","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ero.2025.12.001_bib0022","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","article-title":"Psoriatic arthritis","volume":"7","author":"FitzGerald","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.ero.2025.12.001_bib0023","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000507930","article-title":"Low back pain and sacroiliitis on cross-sectional abdominal imaging for axial spondyloarthritis diagnosis in inflammatory bowel diseases","volume":"5","author":"Fauny","year":"2020","journal-title":"Inflamm Intest Dis"},{"issue":"11","key":"10.1016\/j.ero.2025.12.001_bib0024","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1007\/s10067-023-06695-5","article-title":"Activity of axial spondyloarthritis after one year of anti-tumor necrosis factor therapy among patients with inflammatory bowel diseases","volume":"42","author":"Dalal","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.ero.2025.12.001_bib0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41584-023-00984-8","article-title":"Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies","volume":"19","author":"Cozzi","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.ero.2025.12.001_bib0026","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.dld.2022.07.012","article-title":"Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study","volume":"55","author":"Guillo","year":"2023","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.ero.2025.12.001_bib0027","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR definition of difficult-to-treat rheumatoid arthritis","volume":"80","author":"Nagy","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ero.2025.12.001_bib0028","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1093\/rheumatology\/keab946","article-title":"The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries","volume":"61","author":"Di Giuseppe","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.ero.2025.12.001_bib0029","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/rheumatology\/keaf120","article-title":"Exploring difficult-to-manage axial spondyloarthritis: results from a Dutch clinical practice registry","volume":"64","author":"Smits","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ero.2025.12.001_bib0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11894-015-0477-6","article-title":"Understanding endoscopic disease activity in IBD: how to incorporate it into practice","volume":"18","author":"Christensen","year":"2016","journal-title":"Curr Gastroenterol Rep"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125001272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125001272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T03:52:30Z","timestamp":1787716350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708125001272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S3050708125001272"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2025.12.001","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spondyloarthritis and inflammatory bowel disease: towards a more severe and refractory disease phenotype","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2025.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}